Amgen Petitions Federal Circuit to Reconsider Decision Invalidating Praluent Patents

Published date23 April 2021
Subject MatterPatents,Patent Litigation,Pharmaceutical Patents,Amgen,Motion for Judgment,Patent Invalidity,Pharmaceutical Industry,Sanofi
Law FirmGoodwin

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT